Elabscience® Announces Antibody Technology Upgrade and Product Portfolio Enhancement
Houston, United States, 2025-11-29 — /EPR Network/ — Elabscience®, a leading global biotechnology company dedicated to providing high-quality reagents and services for life science research, today [read full press release…]
